16 matches for your search in the start-up spotlight
rss
AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases. Our differentiation lies in our unique quantum and statistical mechanics algorithms fueling a ...
En Carta Diagnostics is a deeptech start-up developing rapid Point-of-Care molecular diagnostics kits. It focuses on the early diagnosis of Lyme disease as a first application. The company operates a patented molecular diagnostics platform with an exclusive worldwide license. Founded in 2022, En ...
Cure51 is a French 'TechBio' company founded by Nicolas Wolikow and Simon Istolainen, alongside seasoned entrepreneurs and five world-renowned oncology centers: Gustave Roussy Institute (IGR, Paris - France), Leon Bérard Center (CLB, Lyon - France), Charité Universitätsmedizin (Berlin - Germany), ...
AZmed has been the first French company to commercialize AI-powered radiology software. For the last 10 years, the number of medical imaging acts has been multiplied by 2 in OECD countries. In contrast, the number of specialists able to analyze this flow of information has stagnated. Thus, ...
Scienta Lab is a deeptech company developing a unique and proprietary artificial intelligence technology to transform the drug discovery and development process in immunology and inflammation.
Eligo Bioscience is the world leader in microbiome in-vivo gene editing and is advancing a highly differentiated pipeline of precision medicines to address unmet medical needs in immunoinflammation, oncology, and infectious diseases driven by the expression of deleterious bacterial genes. Eligo ...
EG 427 has developed a unique, non-replicative Herpes Simplex Virus type 1 (nrHSV-1) based vector platform. It delivers, with pinpoint precision, highly selective, durable expression of disease modifying transgenes. We take advantage of it to design new treatments of peripheral nervous system ...
Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions. Astraveus's cell foundries miniaturize and automate cell and gene therapy manufacturing in a unique, modular, end-to-end, microfluidic solution that mimics the elegance of natural systems. The deep ...
Founded in 2021, Biomemory offers an original solution for DNA data storage, set apart from the competition by its use of long DNA fragments and innovative synthetic biology processes. As opposed to the synthetic chemical and enzymatic solutions, Biomemory is exploring the potential of a third ...
Created in 2020 and based in Paris, STANDING OVATION aims to become a key player in the food transition. The company is developing the production of fermentative caseins and their transformation into non-animal, lactose-free substitutes for cheese and dairy products. Standing Ovation recently ...
